Atara Biotherapeutics to Present 2020 Key Milestones and Progress in Bringing Off-The-Shelf, Allogeneic T-Cell Immunotherapies to Patients in Need at the 38th Annual J.P. Morgan Healthcare Conference
Key milestones anticipated across Atara’s four strategic priorities in 2020Continued investment in EBV T-cell platform to develop off-the-shelf, allogeneic CAR […]